KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹37 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹34 Cr |
What is the latest Total Non-Current Liabilities ratio of KOPRAN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹33 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹33 Cr |
| Mar2021 | ₹34 Cr |
How is Total Non-Current Liabilities of KOPRAN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 9.64 | |
| Mar2024 | ₹33 Cr | -0.03 | |
| Mar2023 | ₹33 Cr | 1.05 | |
| Mar2022 | ₹33 Cr | -1.59 | |
| Mar2021 | ₹34 Cr | - | |
Compare Total Non-Current Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹954.4 Cr | 2.4% | 8.9% | 3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 2.4% |
8.9% |
3.7% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses